CIK 0001661059
- Non-accelerated filer
- Smaller reporting company
NextCure, Inc.
Sign in to watch- Ticker
- NXTC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 475231247
- Phone
- +1 240-399-4900
- Business address
- 2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
- Open-market buys, last 90 days
- $140,487
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$140,487. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-31 | Langermann Sol Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +117,375 | 117,375 | ||
| 2024-03-29 | Langermann Sol Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +93,900 | 93,900 | ||
| 2024-01-31 | Langermann Sol Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +117,375 | 117,375 | ||
| 2023-02-28 | Langermann Sol Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +135,000 | 135,000 | ||
| 2022-01-31 | Langermann Sol Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +117,400 | 117,400 | ||
| 2021-03-15 | Langermann Sol Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2020-02-28 | Langermann Sol Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +78,200 | 78,200 |
Page 1 of 1 · 7 trades